AtaiBeckley surges after report Lilly poised to buy psychedelic drug developer
AtaiBeckley shares soared 50% premarket on Thursday after a report that Eli Lilly was in talks to acquire the psychedelic drug developer as soon as this week.
July 16, 2026
How to use TIPS in your portfolio
Explosion in tunnel at Indian hydropower project leaves 10 dead and 17 missing
Pop vocalist D4vd faces evidentiary hearing in murder of teenage girl
On sidelines of Iran war, Israel is readying plans in case of escalation
French lawmakers vote on social media ban for children
From 1 to 10: Inside the 20-year status decline of the American passport